Quidel Rounds Out Women's Health Offerings Via Metra Biosystems Buy
This article was originally published in The Gray Sheet
Executive Summary
Quidel's cash acquisition of Metra Biosystems for $23 mil. will help the firm round out its women's health product portfolio.
You may also be interested in...
Quidel Will Seek To Carve Out Niche For QUS-2 In Crowded Market
Quidel is looking to expand the ultrasound bone sonometer market by appealing to an untapped group of physicians interested in providing a point-of-care service with its low cost, portable QUS-2 system.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.